Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/45278


The Pharmaceutical Market: Philippines


Description: THE PHARMACEUTICAL MARKET: PHILIPPINES - REVIEW

The Philippines is projected to be the tenth largest economy in the Asia Pacific region by 2016. High government spending to stimulate the economy has improved conditions temporarily but in turn has created a large budget gap. The Philippines remains on the USTR's Watch List in 2011, primarily due to the fact that “the United States remains concerned about amendments to the patent law that prohibit patents on certain chemical forms unless the applicant demonstrates increased efficacy”. Demographically, the population of the Philippines will be the seventh largest in the Asia Pacific region covered by 2016. The population remains relatively young.

The Philippines has one of the highest drug prices in the world. Changes brought about by the controversial Cheaper Medicine Act have impacted the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. Since the Act's implementation, a considerable number of drugs have seen price reductions by up to half. The immediate term will be the most volatile, as the government battles with the international pharmaceutical industry for ground in the market, which up until recently experienced a free-market policy with no price regulations in place.

The analyst estimates a high single-digit CAGR in US dollar terms for the Philippines pharmaceutical market in the period 2011 to 2016. The Philippines will be the ninth largest pharmaceutical market in the Asia Pacific region by 2016. The Philippines is heavily reliant on imports of finished medicaments, and exports little in way of pharmaceuticals, therefore the deficit in the balance of trade is likely to increase during the forecast period. The Philippines OTC sector is dominated by three Filipino pharmaceutical companies that control over half of this sector. The Philippines generic sector is being actively backed by the government and is led by UniLab.

ENHANCED STRATEGIC INTELLIGENCE

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
- Specialised intelligence on OTCs, generics, biologics and biosimilars.
- Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
- A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
- The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.


Contents: EXECUTIVE SUMMARY
Snapshot: Strategic Espicom Analysis
Snapshot: Key Data Projections
MACROENVIRONMENT
POLITICAL
ECONOMIC
Projections
LEGAL
Intellectual Property Rights
Counterfeit Drugs
DEMOGRAPHIC
Projections
Latest Figures
Demographic Indicators
Births
Deaths
Infant Deaths
Life Expectancy at Birth
EPIDEMIOLOGY
DISEASE BURDEN
Leading Causes of Mortality
DISEASE PREVALENCE
Communicable Diseases
HIV/AIDS
Non-Communicable Diseases
Diabetes
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS
ORGANISATION
EXPENDITURE
Projections
Latest Figures
INFRASTRUCTURE
Inpatient Infrastructure
Outpatient Infrastructure
WORKFORCE
Projections
Current State
REGULATORY AFFAIRS
INTERNATIONAL AUTHORITY
NATIONAL AUTHORITY & REGULATION
National Drug Policy
Cheaper Medicines Law
REGULATORY DEVELOPMENTS
FOURmula One for Health
BFAD Strengthening Law
GOOD MANUFACTURING PRACTICE
MARKETING REGISTRATION
Labelling
Clinical Trials
Fast Track Registrations
BFAD Quality Seal for Pharmaceuticals
Bioavailability/Bioequivalence Registration of Drugs
PROMOTION
Advertising
PRICING & REIMBURSEMENT
PRICING
Further Price Reductions
Government Mediated Access Price
REIMBURSEMENT
DISTRIBUTION CHANNELS
DRUG WHOLESALING
Leading Wholesalers
Diethelm Keller Siber Hegner (DKSH)
Metro Drug
Zuellig
DRUG RETAILING
Leading Pharmacy Chains
Mercury Drug
The Generics Pharmacy
DISTRIBUTION IN THE PUBLIC SECTOR
MARKET ANALYSIS
SIZE
Projections
Historical Figures
PRODUCT DEVELOPMENT
MANUFACTURING
TRADE
Exports
Imports
Parallel Imports
Impact of Parallel Imports on Pharmaceutical Manufacturers
Balance of Trade
COMPETITION
TRADE ASSOCIATIONS
PHAP
PPMA
COMPANY INTELLIGENCE
Domestic Manufacturers
Hizon
La Croesus Pharma
Lloyd Laboratories
Morishita-Seggs
Pascual Laboratories
Pharma Industries
Swiss Pharma
United Laboratories
OTC PHARMACEUTICALS
MARKET SIZE
COMPETITION
Company Intelligence
Intermed Marketing
Pascual Laboratories
United Laboratories
GENERIC PHARMACEUTICALS
LEGAL
Pfizer and United Laboratories Patent Row
REGULATION
COMPETITION
Company Intelligence
Lupin and Multicare
Pharex HealthCorp
United Laboratories
BIOLOGICS & BIOSIMILARS
RESEARCH & DEVELOPMENT
Government to Produce Vaccines under Biotech Initiative
Government Likely to Invest in BioChem Informatics Centre (BIC)
COMPETITION
Company Intelligence
Servac
CONCLUSIONS: OPPORTUNITIES & CHALLENGES
Strategic Espicom Analysis
MACROENVIRONMENT
EPIDEMIOLOGY
HEALTHCARE
REGULATORY AFFAIRS
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
MARKET
COMPETITION
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
Radar Analysis
SWOT Analysis
DIRECTORY
GOVERNMENT ORGANISATIONS
PHARMACEUTICAL COMPANIES
Domestic Companies
TRADE ORGANISATIONS

List of tables

Espicom Analysis of the Pharmaceutical Market, 2011
Key Data Projections, 2011-2016
Political Landscape, 2011
Regional Ranking of Projected Economies, 2016
Projected Economy, 2011-2016
Regional Ranking of Projected Demographics, 2016
Projected Demographics, 2011-2016
Summary of Demographic Indicators
Demographic Indicators, 2001-2008
Eight Leading Reported Notifiable Diseases by Gender, 2008
HIV/AIDS Demographic Data, 1984 – July 2011
Regional Ranking of Projected Expenditure, 2016
Projected Health Expenditure, 2011-2016
Health Expenditure by Source of Funding, 2005-2007 (Million Pesos)
Hospitals by Sector, 1990-2007
Hospital Beds by Sector, 1997-2007
Public Outpatient Facilities, 1997-2007
Regional Ranking of Projected Physicians, 2016
Projected Physicians, 2011-2016
Medical Personnel, 2003-2007
BFAD’s List of Establishments with Certificate of Good Manufacturing Practice (cGMP), 2010
Drug Wholesalers by Region, 2004-2008
Drug Retailers by Region, 2004-2008
Regional Ranking of Projected Pharmaceutical Markets, 2016
Projected Pharmaceutical Market at Retail Prices, 2011-2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010
Registered Drug Manufacturers by Region, 2004-2008
Pharmaceutical Exports by Category, 2005-2009 (US$000s)
Pharmaceutical Exports by Country/Region, 2009 (US$000s)
Pharmaceutical Imports by Category, 2005-2009 (US$000s)
Imports of Raw Materials by Country/Region, 2009 (US$000s)
Imports of Antisera & Vaccines by Country/Region, 2009 (US$000s)
Imports of Medicaments by Country/Region, 2009 (US$000s)
Prices of Parallel Imported Medicines, 2008 (Pesos)
Pharmaceutical Balance of Trade, 2005-2009 (US$000s)
PHAP Members, 2009
PPMA Members, 2009
Espicom Analysis of the Pharmaceutical Market, 2011
SWOT Analysis of the Pharmaceutical Market, 2011

List of Charts

Regional Comparison of Top 6-16 Projected Pharmaceutical Markets at Retail Prices, 2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010
Pharmaceutical Exports, 2003-2009 (US$ Millions)
Pharmaceutical Imports, 2003-2009 (US$ Millions)
Pharmaceutical Imports by Country/Region, 2009 (%)
Pharmaceutical Balance of Trade, 2003-2009 (US$ Millions)
Radar Graph of the Philippines Pharmaceutical Market, 2011




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/45278

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 08:04:49
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The Pharmaceutical Market: Philippines

Web Address:
http://www.researchandmarkets.com/reports/45278

Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (Online Access) - Enterprisewide €5,050.00
Electronic (PDF) - Enterprisewide €5,050.00
Electronic (Online Access) - Single User €775.00
Hard Copy €775.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Single User €775.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 08:04:49


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)